Individualized surveillance of chronic hepatitis B patients according to hepatocellular carcinoma risk based on PAGE-B scores. Issue 12 (December 2021)
- Record Type:
- Journal Article
- Title:
- Individualized surveillance of chronic hepatitis B patients according to hepatocellular carcinoma risk based on PAGE-B scores. Issue 12 (December 2021)
- Main Title:
- Individualized surveillance of chronic hepatitis B patients according to hepatocellular carcinoma risk based on PAGE-B scores
- Authors:
- Kim, Ji Hyun
Kang, Seong Hee
Lee, Minjong
Choi, Hoon Sung
Jun, Baek Gyu
Kim, Tae Suk
Choi, Dae Hee
Suk, Ki Tae
Kim, Moon Young
Kim, Young Don
Cheon, Gab Jin
Baik, Soon Koo
Kim, Dong Joon - Abstract:
- Abstract : Background and aims: Current guidelines for chronic hepatitis B (CHB) patients are to undergo surveillance for hepatocellular carcinoma (HCC) with 6-month ultrasonography. We aimed to compare detection rates of very-early-stage HCC in two groups: group A, undergoing 6-month ultrasonography versus group B, undergoing 6-month ultrasonography alternating with dynamic computed tomography (CT). Methods: This retrospective study assessed 2151 CHB patients under entecavir/tenofovir therapy from 2007 to 2016. Detection rates of very-early-stage HCC were compared between groups A/B at intermediate/high risk based on platelets, age, gender-hepatitis B scores. The primary endpoint was the proportion of patients in each group with very-early-stage HCC. Cox proportional hazards model was used to assess the effect of surveillance modalities to detect very-early-stage HCC. Results: Five-year cumulative HCC incidence rates in group A were 15.0% not significantly different from 18.2% in group B at high risk ( P = 0.17). Detection rates of very-early-stage HCC were significantly higher in group B than in group A ( P < 0.001), and surveillance using CT alternating with ultrasonography was significantly associated with detection of very-early-stage HCC (hazard ratio 3.89, P < 0.001). Among intermediate-risk patients, difference between detection rates of very-early-stage HCC in groups A and B was not significant (P = 0.30), and surveillance using CT alternating with ultrasonographyAbstract : Background and aims: Current guidelines for chronic hepatitis B (CHB) patients are to undergo surveillance for hepatocellular carcinoma (HCC) with 6-month ultrasonography. We aimed to compare detection rates of very-early-stage HCC in two groups: group A, undergoing 6-month ultrasonography versus group B, undergoing 6-month ultrasonography alternating with dynamic computed tomography (CT). Methods: This retrospective study assessed 2151 CHB patients under entecavir/tenofovir therapy from 2007 to 2016. Detection rates of very-early-stage HCC were compared between groups A/B at intermediate/high risk based on platelets, age, gender-hepatitis B scores. The primary endpoint was the proportion of patients in each group with very-early-stage HCC. Cox proportional hazards model was used to assess the effect of surveillance modalities to detect very-early-stage HCC. Results: Five-year cumulative HCC incidence rates in group A were 15.0% not significantly different from 18.2% in group B at high risk ( P = 0.17). Detection rates of very-early-stage HCC were significantly higher in group B than in group A ( P < 0.001), and surveillance using CT alternating with ultrasonography was significantly associated with detection of very-early-stage HCC (hazard ratio 3.89, P < 0.001). Among intermediate-risk patients, difference between detection rates of very-early-stage HCC in groups A and B was not significant (P = 0.30), and surveillance using CT alternating with ultrasonography was not significantly associated with detection of very-early-stage HCC (hazard ratio 1.61, P = 0.23). Conclusion: In high-risk CHB patients, surveillance using CT alternating with ultrasonography led to higher detection rates of very-early-stage HCC compared to surveillance using ultrasonography. Abstract : Supplemental Digital Content is available in the text. … (more)
- Is Part Of:
- European journal of gastroenterology & hepatology. Volume 33:Issue 12(2021)
- Journal:
- European journal of gastroenterology & hepatology
- Issue:
- Volume 33:Issue 12(2021)
- Issue Display:
- Volume 33, Issue 12 (2021)
- Year:
- 2021
- Volume:
- 33
- Issue:
- 12
- Issue Sort Value:
- 2021-0033-0012-0000
- Page Start:
- Page End:
- Publication Date:
- 2021-12
- Subjects:
- chronic hepatitis B -- hepatocellular carcinoma, -- surveillance
Digestive organs -- Diseases -- Periodicals
Liver -- Diseases -- Periodicals
Digestive organs -- Diseases
Liver -- Diseases
Periodicals
616.33 - Journal URLs:
- http://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=toc&D=yrovft&AN=00042737-000000000-00000 ↗
http://www.eurojgh.com/ ↗
http://journals.lww.com/pages/default.aspx ↗ - DOI:
- 10.1097/MEG.0000000000001870 ↗
- Languages:
- English
- ISSNs:
- 0954-691X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3829.729400
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 25397.xml